LINDEN ADVISORS LP - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 48 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$34,850
-48.9%
500,0000.0%0.00%
-100.0%
Q2 2023$68,250
+59.1%
500,0000.0%0.00%
Q1 2023$42,900
+86.5%
500,0000.0%0.00%
Q4 2022$23,000
-68.1%
500,0000.0%0.00%
-100.0%
Q3 2022$72,000
+30.9%
500,0000.0%0.00%0.0%
Q2 2022$55,000
-50.9%
500,0000.0%0.00%0.0%
Q1 2022$112,000500,0000.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 200,049$1,976,0000.04%
Q Global Advisors, LLC 195,694$45,0000.03%
Telemetry Investments, L.L.C. 33,303$7,0000.01%
FIFTH LANE CAPITAL, LP 51,250$12,0000.01%
MARSHALL WACE, LLP 190,150$1,879,0000.00%
CANTOR FITZGERALD, L. P. 250,000$58,0000.00%
MMCAP International Inc. SPC 325,000$75,0000.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 650,866$150,0000.00%
Context Capital Management, LLC 105,069$24,0000.00%
COWEN AND COMPANY, LLC 94,785$22,0000.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders